부산대학교 도서관

Tarazona N; Navarro L; Cejalvo JM; Gambardella V; Pérez-Fidalgo JA; Sempere A; Navarro S; Cervantes A

OncoTargets and Therapy, Vol 2015, Iss default, Pp 1053-1059 (2015)

Makker V; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical Center, New York, NY, USA.; Perez-Fidalgo JA; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Valabrega G; University of Turin, A.O. Ordine Mauriziano, Turin, Italy.; Hamilton E; Sarah Cannon Research Institute, Nashville, TN, USA.; Van Gorp T; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Sehouli J; European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, NOGGO, Charité-Berlin University of Medicine, Berlin, Germany.; Regináčová K; Department of Oncology, University Hospital Kralovske Vinohrady, Prague, Czech Republic; Charles University, Third Faculty of Medicine, Prague, Czech Republic.; Richardson DL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Perri T; Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.; Oza AM; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.; Miller DS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Alía EMG; Hospital Universitario Ramón y Cajal, Madrid, Spain.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.; Henry S; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and Université Catholique de Louvain CHU UCL Site Ste Elisabeth, Service d'onco-hématologie (SORMIN), Namur, Belgium.; Spitz DL; Sarah Cannon Research Institute, Nashville, TN, USA; Florida Cancer Specialists & Research Institute, Wellington, FL, USA.; Wimberger P; University Hospital Carl Gustav Carus, NOGGO, and Technische Universität Dresden, Dresden, Germany.; Bednaříková M; University Hospital and Masaryk University, Brno, Prague, Czech Republic; Charles University, Third Faculty of Medicine, Prague, Czech Republic.; Chon HS; Moffitt Cancer Center, Tampa, FL, USA.; Martínez-Garcia J; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-ARRIXACA, Murcia, Spain.; Pisano C; Istituto Nazionale Tumori di Napoli, Naples, Italy.; Berek JS; Stanford Women's Cancer Center, Stanford Cancer Institute, University School of Medicine, Stanford, CA, USA.; Romero I; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Scambia G; Università Cattolica del Sacro Cuore, Rome 00168, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome 00168, Italy.; Fariñas-Madrid L; Vall d'Hebron Universitiy Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Buscema J; Arizona Oncology, Tucson, AZ, USA.; Schochter F; University Hospital Ulm, Ulm, Germany.; Li K; Karyopharm Therapeutics Inc., Newton, MA, USA.; Kalyanapu P; Karyopharm Therapeutics Inc., Newton, MA, USA.; Walker CJ; Karyopharm Therapeutics Inc., Newton, MA, USA.; Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: Ignace.vergote@uzleuven.be.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Ledermann JA; Department of Oncology, UCL Cancer Institute, University College London, London, UK. Electronic address: clinicalguidelines@esmo.org.; Matias-Guiu X; CIBERONC, Madrid; Department of Pathology, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, University of Lleida, Lleida; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain. Electronic address: admin@esp-pathology.org.; Amant F; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Concin N; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria; Department of Gynaecology and Gynaecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.; Davidson B; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Fotopoulou C; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; González-Martin A; Department of Medical Oncology and Program in Solid Tumours-Cima, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Gourley C; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Leary A; Department of Medicine, Institut Gustave Roussy, Villejuif, France.; Lorusso D; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy.; Banerjee S; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.; Chiva L; Department of Gynaecology and Obstetrics, Cancer Center Clínica Universidad de Navarra, Navarra, Spain.; Cibula D; Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Colombo N; Department of Gynecologic Oncology, Istituto Europeo di Oncologia IRCCS, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.; Croce S; Department of Biopathology, Bergonié Institut, Bordeaux, France.; Eriksson AG; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Gynecologic Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Falandry C; Institute of Aging, Hospices Civils de Lyon, Lyon; CarMeN Laboratory, INSERM U1060/Université Lyon 1/INRAE U1397/Hospices Civils Lyon, Pierre-Bénite, France.; Fischerova D; Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Harter P; Department of Gynaecology and Gynaecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany.; Joly F; GINECO Group, Department of Medical Oncology, Centre François-Baclesse, University of Caen Normandy, Caen, France.; Lazaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain.; Lok C; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Mahner S; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich.; Marmé F; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany; Department of Obstetrics and Gynecology, University Hospital Mannheim, Mannheim; Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Marth C; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.; McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.; McNeish IA; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Morice P; Department of Gynecologic Surgery, Gustave Roussy Cancer Campus, Villejuif, France.; Nicum S; Department of Oncology, UCL Cancer Institute, University College London, London, UK.; Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Pérez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario - INCLIVA, CIBERONC, Valencia, Spain.; Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS Fondazione Pascale, Napoli, Italy.; Ramirez PT; Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, USA.; Ray-Coquard I; Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard, Lyon, France.; Romero I; Department of Medical Oncology, Instituto Valenciano Oncologia, Valencia, Spain.; Scambia G; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy.; Sehouli J; North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin; Department of Gynecology with Center for Oncological Surgery, Charité Berlin University of Medicine, Berlin, Germany.; Shapira-Frommer R; Sheba Medical Center, Ramat Gan, Israel.; Sundar S; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham; Pan Birmingham Gynaecological Cancer Centre, City Hospital, Birmingham, UK.; Tan DSP; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; National University of Singapore (NUS) Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cancer Science Institute, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore, Singapore.; Taskiran C; Department of Gynecologic Oncology, School of Medicine, Koç University, Istanbul, Turkey.; van Driel WJ; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Vergote I; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Planchamp F; Institut Bergonié, Bordeaux, France.; Sessa C; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.; Fagotti A; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy. Electronic address: guidelines@esgo.org.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Eden D; Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, U.K.; Integrated Symptom Control and Palliative Care Team, The Royal Marsden NHS Foundation Trust, London, U.K.; Ghose A; Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, U.K.; Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham, U.K.; Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London, U.K.; Immuno-Oncology Clinical Network, Liverpool, U.K.; Moschetta M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Pérez-Fidalgo JA; Hematology and Medical Oncology Department, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.; Rassy E; Department of Medical Oncology, Gustave Roussy Institut, Villejuif, France.; Boussios S; Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham, U.K.; stergiosboussios@gmail.com stergios.boussios@nhs.net stergios.boussios@kcl.ac.uk s.boussios@kent.ac.uk stergios.boussios@kmms.ac.uk.; Faculty of Medicine, Health, and Social Care, Canterbury Christ Church University, Canterbury, U.K.; Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London, U.K.; Kent Medway Medical School, University of Kent, Canterbury, U.K.; AELIA Organization, Thessaloniki, Greece.

Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

Jhaveri KL; Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York, and Weill Cornell Medical College, New York, New York.; Bellet M; Oncology Department, Breast Cancer Unit, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, and The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Bardia A; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Boni V; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, HM Hospitales Sanchinarro, Madrid, Spain.; Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.; Neilan TG; Division of Cardiology, Department of Medicine, Cardio-Oncology Program, Massachusetts General Hospital, Boston, Massachusetts.; Villanueva-Vázquez R; Institut Català d'Oncologia, l'Hospitalet-Hospital Duran i Reynals, Barcelona, Spain.; Kabos P; School of Medicine, University of Colorado, Aurora, Colorado.; García-Estévez L; Breast Cancer Department, MD Anderson Cancer Center Madrid, Madrid, Spain.; López-Miranda E; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Pérez-Fidalgo JA; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain.; Pérez-García JM; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey.; Yu J; Clinical Pharmacology, Genentech, Inc., South San Francisco, California.; Fredrickson J; Genentech Research and Early Development (gRED), Genentech, Inc., South San Francisco, California.; Moore HM; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.; Chang CW; PHC and Early Development Oncology Biostatistics, Genentech, Inc., South San Francisco, California.; Bond JW; Product Development Safety, Genentech, Inc., South San Francisco, California.; Eng-Wong J; Genentech Research and Early Development (gRED), Genentech, Inc., South San Francisco, California.; Gates MR; Genentech Research and Early Development (gRED), Genentech, Inc., South San Francisco, California.; Lim E; St. Vincent's Hospital and Garvan Institute of Medical Research, University of New South Wales, Sydney, New South Wales, Australia.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Montero P; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Faculty of Health Sciences, Universidad Europea de Valencia, Valencia, Spain.; Sanz C; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Pérez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Biomedical Research Networking Centre on Cancer (CIBERONC), Health Institute Carlos III, Madrid, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain.; Pérez-Leal M; Faculty of Health Sciences, Universidad Europea de Valencia, Valencia, Spain.; Milara J; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, Madrid, Spain.; Pharmacy Unit, University General Hospital Consortium, Valencia, Spain.; Cortijo J; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, Madrid, Spain.; Research and Teaching Unit, University General Hospital Consortium, Valencia, Spain.

Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-8206 (Electronic) Linking ISSN: 07673981 NLM ISO Abbreviation: Fundam Clin Pharmacol Subsets: MEDLINE

Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: aoaknin@vhio.net.; Gladieff L; Oncopole Claudius Regaud, IUCT, Toulouse, France.; Martínez-García J; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; The Institute of Cancer Research, London, UK.; Takekuma M; Shizuoka Cancer Center, Shizuoka, Japan.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy.; Lindemann K; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Oslo University Hospital, Oslo, Norway.; Woelber L; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Colombo N; Gynecologic Oncology Department, European Institute of Oncology IRCCS Milan, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Duska L; University of Virginia Cancer Center, Charlottesville, VA, USA.; Leary A; Gustave Roussy, Villejuif, France.; Godoy-Ortiz A; Hospital Regional de Málaga, Málaga, Spain.; Nishio S; Kurume University Hospital, Fukuoka, Japan.; Angelergues A; Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.; Rubio MJ; Hospital Universitario Reina Sofia, Córdoba, Spain.; Fariñas-Madrid L; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Yamaguchi S; Hyogo Cancer Center, Hyogo, Japan.; Lorusso D; Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Catholic University of Sacred Heart, Rome, Italy.; Ray-Coquard I; Centre Léon Bérard, Lyon, France.; Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Joly F; Centre François Baclesse, Caen, France.; Alarcón J; Hospital Universitari Son Espases, Mallorca, Spain.; Follana P; Centre Antoine Lacassagne, Nice, France.; Romero I; Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.; Lebreton C; Institut Bergonié, Bordeaux, France.; Pérez-Fidalgo JA; University Hospital of Valencia, Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain; CIBERONC, Valencia, Spain.; Yunokawa M; Cancer Institute Hospital of JFCR, Tokyo, Japan.; Dahlstrand H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.; D'Hondt V; Institut du Cancer de Montpellier, Montpellier, France.; Randall LM; Massey Comprehensive Cancer Center, VCUHealth, Richmond, VA, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Vergote I; BGOG, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Pérez-Fidalgo JA; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Spain.; Hamilton EP; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Valabrega G; MITO and Department of Oncology, University of Torino, Mauriziano Hospital, Turin, Italy.; Van Gorp T; BGOG, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Sehouli J; Department of Gynecology, NOGGO, European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, Charité-Berlin University of Medicine, Berlin, Germany.; Cibula D; CEEGOG, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Levy T; Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, ISGO, Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Holon, Israel.; Welch S; London Health Sciences Centre, London, ON, Canada.; Richardson DL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.; Guerra EM; GEICO, Hospital Universitario Ramon y Cajal, Madrid, Spain.; Scambia G; MITO, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Henry S; CHU UCL Namur Site Ste Elisabeth, Service d'onco-hématologie (SORMN), BGOG and Université Catholique de Louvain, Namur, Belgium.; Wimberger P; Department of Obstetrics and Gynecology, University Hospital Carl Gustav Carus, NOGGO and Technische Universitat Dresden, Dresden, Germany.; Miller DS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.; Klat J; University Hospital Ostrava and University of Ostrava, Ostrava-Poruba, Czech Republic.; Martínez-Garcia J; Department of Oncology, GEICO, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.; Raspagliesi F; Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy.; Pothuri B; NYU Langone Health, Perlmutter Cancer Center, New York University School of Medicine, New York, NY.; Romero I; Medical Oncology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.; Bergamini A; Department of Obstetrics and Gynecology, San Raffaele Milano, Milano, Italy.; Università Vita-Salute San Raffaele, Milano, Italy.; Slomovitz B; Mount Sinai Medical Center, Florida International University, Miami, FL.; Schochter F; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Høgdall E; Department of Pathology, Herlev Hospital Copenhagen University Hospital, Copenhagen, Denmark.; Fariñas-Madrid L; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Monk BJ; GOG, HonorHealth, University of Arizona, Creighton University, Phoenix, AZ.; Michel D; Karyopharm Therapeutics, Newton, MA.; Kauffman MG; Karyopharm Therapeutics, Newton, MA.; Shacham S; Karyopharm Therapeutics, Newton, MA.; Mirza MR; Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.; Makker V; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Perez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain japfidalgo@msn.com.; Guerra E; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; García Y; Department of Medical Oncology, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí I3PT. Universitat Autònoma de Barcelona, Sabadell, Spain.; Iglesias M; Department of Medical Oncology, Hospital Son Llatzer, Palma De Mallorca, Palma de Mallorca, Spain.; Hernández-Sosa M; Department of Medical Oncology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas De Gran Canaria, Spain.; Estevez-García P; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Manso Sánchez L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Santaballa A; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Oaknin A; Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Redondo A; Department of Medical Oncology, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Rubio MJ; Department of Medical Oncology, Hospital Universitario Reina Sofia, Cordoba, Spain.; González-Martín A; Department of Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain.

Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

Perez-Fidalgo JA; Department of Medical Oncology, Hospital Clinico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain. Electronic address: japfidalgo@msn.com.; Martinelli E; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy. Electronic address: https://twitter.com/grikamartinelli.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE